Total and free deoxypyridinoline after acute osteoclast activity inhibition

Clinical Chemistry

Volumn 45, Issue 9, 1999, Pages 1510-1516

  Rubinacci, Alessandro ^a   Melzi, Raffaella ^a   Zampino, Maria ^a   Soldarini, Armando ^a   Villa, Isabella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; PYRIDINIUM DERIVATIVE;

ACCURACY; ADULT; AGED; ARTICLE; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OSTEOCLAST; OSTEOLYSIS; URINARY EXCRETION;

EID: 0032863547     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Robins SP. Collagen crosslinks in metabolic bone disease. Acta Orthop Scand Suppl 1995;266:171-5.
2. Kamel S, Brazier M, Neri V, Picard C, Samson L, Desmet G, Sebert JL. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods. J Bone Miner Res 1995;10:1385-92.
3. Roux GP, Arlot ME, Gineyts E, Meunier PJ. Delmas PD. Automatic-interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline. Bone 1995;17: 153-6.
4. Eastell R, Colwell A, Hampton L, Reeve J. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res 1997;12:59-65.
5. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on lilac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991;6:639-44.
6. Vinholes J, Guo CY, Purohit OP, Eastell R, Coleman RE. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. J Clin Oncol 1997;15:131-8.
7. Blumsohn A, Naylor KE, Assiri AMA, Eastell R. Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clin Chem 1995;41:1592-8.
8. Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, et al. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 1996;11:1176-84.
9. Marabini R, Sirtori P, Chionna R, Barzizza L, Rubinacci A. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy. J Endocrinol Investig 1996;19:154-8.
10. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996; 81:37-43.
11. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-700.
12. Sirtori P, Sosio C, Polo RM, Tenni R, Rubinacci A. A comparative study on biochemical markers of bone collagen breakdown in postmenopausal women. Pharmacol Res 1997;36:229-35.
13. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643-9.
14. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
15. Parfitt AM. Calcium homeostasis. In: Mundy GR, Martin TJ, eds. Physiology and pharmacology of bone. Berlin: Springer Verlag, 1993:1-65.
16. Fuss M, Pepersack T, Corvilain J, Bergmann P, Willems D, Simon J, et al. Stimulation of calcitonin secretion by an oral calcium load test in normal subjects and in idiopathic renal stone formers. Bone Miner 1991;13:131-7.
17. Horowitz M, Need AG, Philcox JC, Nordin BEC. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women. Horm Metab Res 1985;17:311-2.
18. Rubinacci A, Divieti P, Polo RM, Zampino M, Resmini G, Tenni R. Effect of an oral calcium load on the urinary markers of collagen breakdown. J Endocrinol Investig 1996;19:719-26.
19. Horowitz M, Wishart JM, Goh D, Morris H, Need AG, Nordin BEC. Oral calcium suppresses biochemical markers of bone resorption in normal men. Am J Clin Nutr 1994;60;965-8.
20. Scopacasa F, Horowitz M, Wishart JM, Need AG, Morris HA, Wittert G, Nordin BEC. Calcium supplementation suppresses bone resorption in early postmenopausal women. Calcif Tissue Int 1998; 62:8-12.
21. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endecrinol Metab 1995;80:3304-10.
22. Favus MJ. Dynamic tests. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia, PA: Lippincott-Raven, 1996:459-62.
23. Schlemmer A, Hassager C, Jenson SB, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992;74:476-80.
24. Ju HS, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997;43:1570-6.
25. Black D, Duncan A, Robins SP. Quantitative analysis of pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988; 197-203.
26. Gerrits MI, Thijssen JHH, van Rijn JM. Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability. Clin Chem 1995;41:571-4.
27. Reginster JY, Denis D, Bartsch V, Deroisy R, Zegels B, Franchimont P. Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporosis Int 1993; 3:271-5.
28. Shires R, Kessler GM. The absorption of tricalcium phosphate and its acute metabolic effects. Calcif Tissue Int 1990;47:142-4.
29. Need AG, Horowitz M, Philcox JC, Nordin BEC. Biochemical effects of calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium. Miner Electrolyte Metab 1987;13:112-6.
30. Morris HA, Need AG, Horowitz M, O'Loughlin, Nordin BEC. Calcium absorption in normal and osteoporotic post menopausal women. Calcif Tissue Int 1991;49:240-3.
31. Ernst M, Schmid CH, Froesch ER. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci U S A 1988;85:2307-10.
32. Holland NEF, Studd JWW, Mansell JP, Leather AT, Bailey AJ. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynecol 1994;83:180-3.
33. Guenther HL, Guenther HE, Fleisch HA. The influence of 1-hydroxyethane-1,1-diphosphonate and dichloromethylenebisphosphonate on lysine hydroxylation and cross-link formation in rat bone, cartilage and skin collagen. Biochem J 1981;196:303-10.
34. Egger CD, Mühlbauer RC, Felix R, Delmas PD, Marks SC, Fleisch H. Evaluation of urinary crosslink excretion as a marker of bone resorption in the rat. J Bone Miner Res 1994;1211-9.
35. Schlemmer A, Hassager C, Alexandersen P, Fledelius C, Pedersen BJ, Kristensen IO, et al. Circadian variation in bone resorption is not related to serum cortisol. Bone 1997;21:83-8.
36. Schlemmer A, Hassager C, Pedersen BJ, Christiansen C. Posture, age, menopause and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J Bone Miner Res 1994;9:1883-8.
37. Colwell A, Eastell R. Renal clearance of free and conjugated pyridinium crosslinks of collagen. J Bone Miner Res 1996;11: 1976-80.